Glenmark Pharmaceuticals zooms as its arm enters into licensing agreement with AbbVie

11 Jul 2025 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 2173.60, up by 268.45 points or 14.09% from its previous closing of Rs. 1905.15 on the BSE.

The scrip opened at Rs. 2095.65 and has touched a high and low of Rs. 2286.15 and Rs. 2095.65 respectively. So far 501878 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2286.15 on 11-Jul-2025 and a 52 week low of Rs. 1274.70 on 28-Feb-2025.

Last one week high and low of the scrip stood at Rs. 2286.15 and Rs. 1793.50 respectively. The current market cap of the company is Rs. 60649.19 crore.

The promoters holding in the company stood at 46.65%, while Institutions and Non-Institutions held 37.80% and 15.56% respectively.

Glenmark Pharmaceuticals’ step-down wholly-owned subsidiary - Ichnos Glenmark Innovation’s (IGI) wholly owned subsidiary IGI Therapeutics SA and AbbVie have entered into an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT protein platform, for oncology and autoimmune diseases. 

Under the terms of the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China. Subject to regulatory clearance, IGI will receive an upfront payment of $700 million and is eligible to receive up to $1.225 billion in development, regulatory, and commercial payments, along with tiered, double-digit royalties on net sales.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1966.05 -19.30 (-0.97%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×